The impact of PD-L1 polymorphisms on the efficacy of immune checkpoint inhibitors depends on the tumor proportion score: a retrospective study
Abstract Purpose This study aims to clarify the relationship between rs2282055, a single-nucleotide polymorphism (SNP) in programmed death-ligand 1 (PD-L1), and TPS. Polcaro et al. (2024) showed that rs822336, a SNP in PD-L1, predicts the effect of immune checkpoint inhibitors (ICIs). However, the s...
Saved in:
Main Authors: | Keiichiro Suminaga, Takashi Nomizo, Hironori Yoshida, Hiroaki Ozasa |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer
2025-02-01
|
Series: | Journal of Cancer Research and Clinical Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1007/s00432-024-06081-x |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Macrophages facilitate tumor cell PD‐L1 expression via an IL‐1β‐centered loop to attenuate immune checkpoint blockade
by: Cheng Xu, et al.
Published: (2023-04-01) -
Impact of Immune Checkpoint Inhibitors and Local Radical Treatment on Survival Outcomes in Synchronous Oligometastatic NSCLC
by: Mandy Jongbloed, MD, et al.
Published: (2025-03-01) -
The prognostic value of circulating tumor DNA in malignant melanoma patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis
by: Lei Liu, et al.
Published: (2025-01-01) -
Association between Interferon-Inducible Protein 6 () Polymorphisms and Hepatitis B Virus Clearance
by: Geun-Hee Park, et al.
Published: (2013-03-01) -
Role of the TGF-β cytokine and its gene polymorphisms in asthma etiopathogenesis
by: Jacek Plichta, et al.
Published: (2025-01-01)